Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Felix Jerusalem is active.

Publication


Featured researches published by Felix Jerusalem.


Neurology | 1975

Human muscle fiber fine structure Morphometric data on controls

Felix Jerusalem; Andrew G. Engel; Hamlet A. Peterson

Muscle fiber fine structure was quantitatively analyzed in 70 longitudinally and 65 transversely sectioned fibers from 10 control subjects without weakness. The average mitochondrial fraction of the fiber volume is close to 4 percent and the mean size of a mitochondrion is about 0.1 μm2. The sarcotubular surface area per unit fiber volume is close to 1.5 μm2/μm3 in transverse sections and 0.65 times this value in longitudinal sections. Only one-third of all fibers contain lipid droplets in the sectioned plane, and for all fibers the droplets account for approximately 0.12 percent of the fiber volume. Variations with the age and sex of the subjects and with different muscles were analyzed and the feasibility of typing human muscle fibers at the ultrastructural level was evaluated.


Neurology | 1983

A dominantly inherited myopathy with excessive tubular aggregates

Reinhard Rohkamm; Konstantin Boxler; Kenneth Ricker; Felix Jerusalem

We studied a family in which seven individuals in three generations had slowly progressive weakness without atrophy, myalgia, cramps, or episodic weakness. Creatine kinase was normal, and EMG showed only slight “Inyopathic” changes. Neuromuscular transmission was undisturbed. Muscle biopsies were performed in three patients. About 60 to 90% of all fibers contained tubular aggregates. There was a marked variation in fiber size and a marked type I1 fiber atrophy. Biopsy of an asymptomatic family member was normal. The nature of the underlying disease was obscure.


Journal of the Neurological Sciences | 1990

Exogenous coenzyme Q (CoQ) fails to increase CoQ in skeletal muscle of two patients with mitochondrial myopathies

Stephan Zierz; Ortgies von Wersebe; Johannes Bleistein; Felix Jerusalem

Recently, several studies were published on therapy with coenzyme Q (CoQ) in patients with mitochondrial myopathies without biochemically established muscular deficiency of CoQ. Two patients with mitochondrial myopathies presenting as oculocraniosomatic syndromes were treated with coenzyme Q (CoQ). The muscle biopsy of both patients showed ragged-red fibers and single muscle fibers without histochemical reaction for cytochrome c oxidase. Biochemical analysis revealed normal activities of the respiratory chain complexes in muscle and normal levels of CoQ in serum and muscle. After one year of treatment CoQ in serum of both patients had increased 1.4-fold and 2.0-fold, respectively. In muscle, however, there was no increase of CoQ in either patient. In both patients the activities of citrate synthase and of the respiratory chain complexes I + III and IV, and in 1 patient also of complex II + III, were lower in the second biopsy compared with the first biopsy. In both patients there was no improvement of maximal isometric muscle strength assessed by a quantitative electronic strain gauge. The exercise-induced pathological rise of lactate in 1 patient remained essentially unchanged during therapy. The data indicate that orally administered CoQ fails to increase total CoQ in muscle of patients with mitochondrial myopathies but without muscular CoQ deficiency.


Neurology | 1995

Cytochrome c oxidase in Alzheimer's disease

Iris Maurer; Zierz S; Hans-Jürgen Möller; Felix Jerusalem

1. Alhalabi M, Moore PM. Serial angiography in isolated angiitis of the central nervous system. Neurology 1994;44:1221-1226. 2. Sigal LH. The neurologic presentation of vasculitic and rheumatologic syndromes. Medicine 1987;66:157-180.. 3. Moore PM. Diagnosis and management of isolated angiitis of the central nervous system. Neurology 1989;39:167-173. 4. Melanson M, Georgevich L, Fett C, et al. PCR detection of VZV DNA in a patient with delayed contralateral hemiplegia [abstract]. Neurology 1994;44(suppl2):A394. 5. Puchhammer-Stock1 E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C. Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol 1991;29:1513-1516. 6. Hostetler J, Rossiter JP, Robertson DM, Brunet DG. Patterns of vascular involvement in primary angiitis of the central nervous system [abstract]. Can J Neurol Sci 1993;(suppl4):246. 7. Fryer DG, Crane R, Margolis T. Angiographic changes in intracranial arteritis of ophthalmic herpes zoster. Ann Neurol 1984;15:311-312. 8. Mayo DR, Booss J. Varicella zoster-associated neurologic disease without skin lesions. Arch Neurol 1989;46:313-315. 9. Gilden DH, Dueland AN, Devlin ME, Mahalingam R, Cohrs R. Varicella-zoster virus reactivation without rash. J Infect Dis 1992; 166:30-34. Table. Activities of electron transport chain enzymes in brain regions of four patients with Alzheimer’s disease and five age-matched controls I Frontal Temporal HippoCerecortex cortex campus bellum


Journal of Neurology | 1994

Abnormal dystrophin expression in patients with limb girdle syndromes

Stefan Beyenburg; Stephan Zierz; Kiichi Arahata; Rustam R. Mundegar; Waltraut Friedl; Felix Jerusalem

Clinical differential diagnosis between Becker muscular dystrophy (BMD) and limb gridle muscular dystrophy (LGMD) may be difficult because the BMD clinical phenotype tends to overlap with other limb girdle syndromes, especially with LGMD. Therefore we studied the expression of dystrophin, the protein product of the Becker and Duchenne muscular dystrophy gene, in muscle biopsy specimens of 30 patients (18 males, of whom 15 represented spradic cases, and 12 females) diagnosed as having LGMD according to traditional clinical, electrophysiological and histological criteria. For dystrophin analysis, six different monoclonal antibodies directed against different epitopes of the dystrophin molecule were used. Immunocytochemically, five of the 30 LGMD patients (17%) showed abnormal dystrophin staining patterns diagnostic of BMD. Western blotting in these five patients, all sporadic cases, showed dystrophin of reduced size and/or abundance. Analysis of blood or muscle DNA using multiplex polymerase chain reaction revealed deletions in the dystrophin gene in three of the five. Thus, 5 of 15 (33%) sporadic male patients previously thought to have LGMD were identified as having BMD.


Journal of the Neurological Sciences | 1997

Sporadic adult-onset distal myopathy with rimmed vacuoles, 15–18 nm tubulofilaments and extensive rod formation

Jörn P. Sieb; Joachim VonOertzen; K. Tolksdorf; Petra Dörfler; Karin Kappes-Horn; Felix Jerusalem

Starting after the age of 35 years this German man had a slowly progressive distal myopathy greater in the legs than in the arms. First he realized gait difficulties with reduced ankle dorsiflexion. Serum creatine kinase activity was normal. Muscle biopsy studies showed myopathic changes, rimmed vacuoles and the presence of rods in 66% of the type 1 muscle fibers. Ultrastructural examination revealed cytoplasmatic aggregates of tubulofilaments measuring 15-18 nm in diameter, myeloid bodies and rod formation. The nosological situation of this distal myopathy with tubulofilamentous inclusions is discussed.


JAMA Neurology | 1998

Proton Magnetic Resonance Spectroscopy of the Primary Motor Cortex in Patients With Motor Neuron Disease: Subgroup Analysis and Follow-up Measurements

Wolfgang Block; Jochen Karitzky; Frank Träber; Christoph Pohl; E. Keller; Rustam R. Mundegar; Rolf Lamerichs; Hermann Rink; Fernand Ries; Hans H. Schild; Felix Jerusalem


Brain | 1974

Duchenne dystrophy. I. Morphometric study of the muscle microvasculature.

Felix Jerusalem; Andrew G. Engel; Manuel R. Gomez


JAMA Neurology | 1973

Mitochondria-Lipid-Glycogen (MLG) Disease of Muscle: A Morphologically Regressive Congenital Myopathy

Felix Jerusalem; Corrado Angelini; Andrew G. Engel; Robert V. Groover


Brain | 1974

DUCHENNE DYSTROPHY: II. MORPHOMETRIC STUDY OF MOTOR END-PLATE FINE STRUCTURE

Felix Jerusalem; Andrew G. Engel; Manuel R. Gomez

Collaboration


Dive into the Felix Jerusalem's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christoph Pohl

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge